REFERENCIAS DE EARLYCDT— LUNG PARA ESTRATIFICAR DE PACIENTES DE RIESGO

Detection in Blood of Autoantibodies to Tumour Antigens as a Case-Finding Method in Lung Cancer Using the EarlyCDT—Lung Test (ECLS): Study Protocol for a Randomized Controlled Trial. Sullivan FM, Farmer E, Mair FS, et al. BMC Cancer. 2017; 17:187.

Progress with an RCT of the Detection of Autoantibodies to Tumour Antigens in Lung Cancer Using the EarlyCDT—Lung Test in Scotland (ECLS). Sullivan F & Schembri S. J Thorac Oncol. 2015; 10(Suppl 2):S306.

Audit of the Autoantibody Test, EarlyCDT—Lung, in 1600 Patients: An Evaluation of its Performance in Routine Clinical Practice. Jett JR, Peek LJ, Fredericks L, et al. Lung Cancer. 2014; 83:51–55.

  Parque Científico Universidad de Valencia | C/Catedrático Agustín Escardino, Nº 9,  46980 Paterna